Clinical trialNCT02138916CompletedPhase 3Interventional

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

SponsorAstraZenecaEnrollment1,656Moderate to Very Severe Chronic Obstructive Pulmonary Disease

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Gerard Criner, MD
Temple University School of Medicine, 3401 North Broad Street, Suite 745 PP, Philadelphia, PA 19140
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

407 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria

Research Site
Feldkirch, Austria
Research Site
Graz, Austria
Research Site
Innsbruck, Austria
Research Site
Linz, Austria
Research Site
Salzburg, Austria
Research Site
Vienna, Austria
Research Site
Wels, Austria

Canada

Research Site
Calgary, Alberta, Canada
Research Site
Calgary, Alberta, Canada
Research Site
Sherwood Park, Alberta, Canada
Research Site
Vancouver, British Columbia, Canada
Research Site
Vancouver, British Columbia, Canada
Research Site
Ajax, Ontario, Canada
Research Site
Burlington, Ontario, Canada
Research Site
Grimsby, Ontario, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Pointe-Claire, Quebec, Canada
Research Site
Québec, Quebec, Canada
Research Site
Québec, Quebec, Canada
Research Site
Québec, Quebec, Canada
Research Site
Saint-Charles-Borromée, Quebec, Canada
Research Site
Trois-Rivières, Quebec, Canada
Research Site
Saskatoon, Saskatchewan, Canada

Czechia

Research Site
Jindřichův Hradec, Czechia
Research Site
Karlovy Vary, Czechia
Research Site
Kralupy nad Vltavou, Czechia
Research Site
Mladá Boleslav, Czechia
Research Site
Olomouc, Czechia
Research Site
Prague, Czechia
Research Site
Rokycany, Czechia
Research Site
Strakonice, Czechia
Research Site
Teplice, Czechia

Germany

Research Site
Bamberg, Germany
Research Site
Berlin, Germany
Research Site
Berlin, Germany
Research Site
Bonn, Germany
Research Site
Frankfurt, Germany
Research Site
Frankfurt am Main, Germany
Research Site
Frankfurt am Main, Germany

367 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 13 Jun 2014
Primary completion: 10 Apr 2018
Completion: 10 Apr 2018
Last update posted: 13 Jun 2019
Registered enrollment: 1,656
Registry id: NCT02138916

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.